Compound information
- Natural Products
- ZC303387
- Molecular Formula
- C16H20N2O6
- Molecular Weight
- 336.13213636 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2S)-1-benzyloxycarbonylpyrrolidine-2-carbonyl]amino]-3-hydroxy-propanoic acid
- InChI
- InChI=1S/C16H20N2O6/c19-9-12(15(21)22)17-14(20)13-7-4-8-18(13)16(23)24-10-11-5-2-1-3-6-11/h1-3,5-6,12-13,19H,4,7-10H2,(H,17,20)(H,21,22)/t12-,13-/m0/s1
- InChI Key
- PMGNCMOZLHZLBM-STQMWFEESA-N
- SMILES
- O=C(O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1
- Source
- ZINC000001576175
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 116.17 Å2 | LogP | 0.396 |
LogS | -1.941 | LogD | -0.5 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.028 |
HIA | 0.844 | F20 % | 0.725 |
F30 % | 0.025 | Caco-2 | -6.23 |
MDCK | -5.817 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.041 | PPB | 58.367 |
VD | 0.451 | Fu | 0.329 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.618 |
CYP2A6 substrate | 0.599 | CYP2B6 substrate | 0.601 |
CYP2C19 inhibitor | 0.112 | CYP2C19 substrate | 0.913 |
CYP2C8 substrate | 0.742 | CYP2C9 inhibitor | 0.025 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.031 |
CYP2D6 substrate | 0.712 | CYP2E1 substrate | 0.164 |
CYP3A4 inhibitor | 0.023 | CYP3A4 substrate | 0.963 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.828 | CL | 3.794 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.822 |
Mutagenicity | 0.05 | Rat Oral Acute Toxicity | 0.158 |
FDAMDD | 0.125 | Skin Sensitization | 0.002 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.007 |
Eye Irritation | 0.384 | Respiratory Toxicity | 0.009 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.364 | IGC50 | 1.787 |
LC50FM | 2.217 | LC50DM | 4.851 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.498 | NR-AR-LBD | 0.358 |
NR-AhR | 0.004 | NR-Aromatase | 0.042 |
NR-ER | 0.399 | NR-ER-LBD | 0.376 |
NR-PPAR-gamma | 0.406 | SR-ARE | 0.049 |
SR-ATAD5 | 0.291 | SR-HSE | 0.122 |
SR-MMP | 0.008 | SR-p53 | 0.023 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.